Trends in emergency department visits for unsupervised pediatric medication exposures, 2004-2013

Pediatrics

Volumn 136, Issue 4, 2015, Pages e821-e829

  Lovegrove, Maribeth C ^a   Weidle, Nina J ^b   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Chenega Government Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUSSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIPHENHYDRAMINE; IBUPROFEN; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; PARACETAMOL; PRESCRIPTION DRUG;

ARTICLE; CAREGIVER; CHILD; EMERGENCY CARE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; TREND STUDY; ADOLESCENT; DRUG MISUSE; DRUG SURVEILLANCE PROGRAM; HOSPITAL EMERGENCY SERVICE; PEDIATRICS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; TRENDS; UNITED STATES;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; MALE; PEDIATRICS; PRESCRIPTION DRUG MISUSE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84942919795     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-2092     Document Type: Article

References (34)

1. -16 CFR x 1700.14 Subchapter E-Poison Prevention Packaging Act of 1970 Regulations, Part 1700-Poison Prevention Packaging. 38 FR 21247, Aug. 7, 1973, as amended at 41 FR 22266, June 2, 1976; 48 FR 57480, Dec 30, 1983
2. Rodgers GB. The safety effects of childresistant packaging for oral prescription drugs. Two decades of experience. JAMA. 1996; 275 (21): 1661-1665
3. Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report. Clin Toxicol (Phila). 2012; 50 (10): 911-1164
4. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th annual report. Clin Toxicol (Phila). 2013; 51 (10): 949-1229
5. Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st annual report. Clin Toxicol (Phila). 2014; 52 (10): 1032-1283
6. Bond GR, Woodward RW, Ho M. The growing impact of pediatric pharmaceutical poisoning. J Pediatr. 2012; 160 (2): 265-270 e261
7. Budnitz DS, Salis S. Preventing medication overdoses in young children: An opportunity for harm elimination. Pediatrics. 2011; 127 (6). Available at: Www.pediatrics.org/cgi/content/full/127/6/e1597
8. Agarwal M, Williams J, Tavoulareas D, Studnek JR. A brief educational intervention improves medication safety knowledge in grandparents of young children. AIMS Public Health. 2015; 2 (1): 44-55
9. HealthyPeople.gov. Healthy People 2020 medical product safety objectives. Available at: Www.healthypeople.gov/2020/topics-objectives/topic/medicalproduct-safety/objectives. Accessed January 20, 2015
10. Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES). Med Care. 2007; 45 (10 suppl 2): S96-S102
11. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006; 296 (15): 1858-1866
12. Wolters Kluwer Health. Facts & Comparisons. Available at: Www.wolterskluwercdi.com/facts-comparisons-online/. Accessed August 7, 2015
13. US Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available at: Www.accessdata.fda.gov/scripts/cder/ob/default.cfm. Accessed August 7, 2015
14. Schroeder T, Ault K. The NEISS sample (design and implementation) 1997 to present. Available at: Www.cpsc.gov//PageFiles/106617/2001d011-6b6.pdf. Accessed February 12, 2015
15. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19 (3): 335-351
16. Burghardt LC, Ayers JW, Brownstein JS, Bronstein AC, Ewald MB, Bourgeois FT. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics. 2013; 132 (1): 18-27
17. Spiller HA, Beuhler MC, Ryan ML, Borys DJ, Aleguas A, Bosse GM. Evaluation of changes in poisoning in young children: 2000 to 2010. Pediatr Emerg Care. 2013; 29 (5): 635-640
18. Budnitz DS, Lovegrove MC. The last mile: Taking the final steps in preventing pediatric pharmaceutical poisonings. J Pediatr. 2012; 160 (2): 190-192
19. Lovegrove MC, Hon S, Geller RJ, et al. Efficacy of flow restrictors in limiting access of liquid medications by young children. J Pediatr. 2013; 163 (4): 1134-1139.e1
20. Schoenewald S, Kuffner E. Unit dose packaging may decrease amount of over-The-counter (OTC) medicine ingested following accidental unsupervised ingestions (AUIs) [NACCT abstract 271]. Clin Toxicol (Phila). 2010; 48 (6): 660
21. ASTM International. Flow control devices. ASTM Standardization News. Available at: Www.astm.org/sn/update/liquidmedicine-flow-control-devices-ja13.html. Accessed March 6, 2015
22. Consumer Healthcare Products Association. OTC industry announces voluntary transition to one concentration of single-ingredient pediatric liquid acetaminophen medicines [press release]. Available at: Www.chpa.org/05-04-11-pedacet.aspx. Accessed March 6, 2015
23. US Food and Drug Administration. Guidance for industry: Over-The-counter pediatric oral liquid drug products containing acetaminophen. Available at: Www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM417568.pdf. Accessed August 7, 2015
24. Lovegrove MC, Mathew J, Hampp C, Governale L, Wysowski DK, Budnitz DS. Emergency hospitalizations for unsupervised prescription medication ingestions by young children. Pediatrics. 2014; 134 (4). Available at: Www.pediatrics.org/cgi/content/full/134/4/e1009
25. Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G. Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996; 49 (4): 255-259
26. -16 CFR x 1700.20 Subchapter E-Poison Prevention Packaging Act of 1970 Regulations, Part 1700-Poison Prevention Packaging. 38 FR 21247, Aug. 7, 1973, as amended at 60 FR 37735, 37738, July 22, 1995
27. Lavonas EJ, Banner W, Bradt P, et al. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. J Pediatr. 2013; 163 (5): 1377-1383.e1-3
28. Schoenewald S, Ross S, Bloom L, et al. New insights into root causes of pediatric accidental unsupervised ingestions of over-The-counter medications. Clin Toxicol (Phila). 2013; 51 (10): 930-936
29. Teutsch SM. Considerations in planning a surveillance system. In: Lee LM, Teutsch SM, Thacker SB, St. Louis ME, eds. Principles & Practice of Public Health Surveillance. 3rd ed. Oxford, New York: Oxford University Press; 2010: 22
30. Dal Pan GJ, Lindquist M, Gelperin K. Postmarketing spontaneous pharmacovigilance reporting systems. In: Strom BL, Kimmel SE, Hennessy S, eds. Pharmacoepidemiology. 5th ed. West Sussex, UK: Wiley-Blackwell; 2012: 150-151
31. UpAndAway.org. Put your medicines up and away and out of sight. Available at: Www.upandaway.org/. Accessed March 6, 2015
32. Centers for Disease Control and Prevention. The PROTECT Initiative: Advancing children's medication safety. Available at: Www.cdc.gov/MedicationSafety/protect/protect-Initiative.html. Accessed March 9, 2015
33. American Academy of Pediatrics. Medication safety (video). Available at: Www.healthychildren.org/English/safety-prevention/at-home/medication-safety/Pages/Medication-Safety-Video.aspx. Accessed March 23, 2015
34. Baker J, Mickalide A. Safe Storage, Safe Dosing, Safe Kids: A Report to the Nation on Safe Medication. Washington, DC: Safe Kids Worldwide; March 2012